HomeHealthcare"In Europe, France is...

“In Europe, France is no longer a priority in the allocation of drug stocks.”

Philippe Lamoureux is the CEO of Entreprises duMedicine (Leem), a professional organization for pharmaceutical laboratories.

LE FIGARO. – The government is working on the revaluation of 10 Percentage of prices of some medicines. Are prices the answer to scarcity? ?

Philippe LAMOUREUX. – This will not solve everything, because the lack of medicines is multifactorial. All it takes is for a raw material supplier to close in Asia for the Chinese authorities to change their recommendations for pathology management or for a biologics manufacturer to face non-compliant batches that must be destroyed. for example creating tension throughout the supply chain. The fact remains that France has the lowest prices in Europe, which weakens the conditions for drug exploitation. We do not have priority in allocating stocks in case of supply tension.

The price hike allows…

Source: Le Figaro

- A word from our sponsors -

Most Popular

LEAVE A REPLY

Please enter your comment!
Please enter your name here

More from Author

- A word from our sponsors -

Read Now